Reduction of contrast induced nephropathy (CIN) in patients requiring a percutaneous coronary intervention procedure and have chronic renal failure.

Multi-centre, single arm study to evaluate performance and safety of the CINCOR contrast media removal system in chronic renal disease patients requiring a percutaneous coronary intervention procedure.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12612000238875

Enrollment

Registered

2012-02-24

Start date

2012-01-12

Completion date

2012-11-12

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

The purpose of the study is to help reduce the incidence of contrast induced nephropathy in patients who have impaired kidney function and required a purcutaneous coronary intervention procedure (e.g. stent) due to cardiovascular disease.

Interventions

CINCOR contrast removal system removes contrast from the circulatory system before it can reach the kidneys. The system uses a canula inserted into the circulatory system that removes contrast media. The procedure occurs at the same time as the percutaneous coronary procedure.

Study design

Allocation

Non-randomised trial

Intervention model

Single group

Primary purpose

Prevention

Masking

Open (masking not used)

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Chronic renal disease and requires a percutaneous coronary intervention procedure.

Exclusion criteria

Not eligable for percutaneous coronary procedure or has an allergy to contrast media, unable/unwilling to provide consent, is pregnant.

Outcome results